A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile, the group taking Zepbound (sold as Mounjaro for weight loss in some markets) also saw greater improvements in blood pressure, blood glucose, and cholesterol levels.

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users.